Kaufmann Michael C
Insider transactions at 2 companies
This page shows all SEC Form 4 filings attributed to Kaufmann Michael C. Form 4 disclosures are required whenever a corporate insider — director, officer, or 10%+ shareholder — buys, sells, or receives company stock. Each row represents a separate reported transaction. All data is sourced directly from the SEC EDGAR public database.
| Company | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| MSM | Option Exercise | 20 | — | — | Jan 25, 2025 | |
| MSM | Option Exercise | 26 | — | — | Jan 26, 2024 | |
| MSM | Sale | 18 | $79.46 | $1,430 | May 4, 2023 | |
| MSM | Option Exercise | 748 | — | — | Jan 27, 2023 | |
| MSM | Option Exercise | 761 | — | — | Jan 26, 2023 | |
| CAH | CEO | Tax Withholding | 94,529 | $69.32 | $6,552,750 | Aug 15, 2022 |
| CAH | CEO | Award / Grant | 132,857 | — | — | Aug 9, 2022 |
| CAH | CEO | Tax Withholding | 9,523 | $54.86 | $522,432 | Jun 28, 2022 |
| MSM | Option Exercise | 105 | — | — | Jan 29, 2022 | |
| MSM | Option Exercise | 748 | — | — | Jan 27, 2022 | |
| CAH | CEO | Tax Withholding | 2,798 | $46.23 | $129,352 | Dec 1, 2021 |
| CAH | CEO | Award / Grant | 85,106 | — | — | Aug 15, 2021 |
| CAH | CEO | Option Exercise | 76,909 | $41.60 | $3,199,414 | Aug 12, 2021 |
| CAH | CEO | Award / Grant | 98,866 | — | — | Aug 3, 2021 |
| CAH | CEO | Tax Withholding | 6,962 | $57.28 | $398,783 | Jun 28, 2021 |
| MSM | Option Exercise | 219 | — | — | Jan 29, 2021 | |
| CAH | CEO | Tax Withholding | 3,206 | $54.59 | $175,016 | Dec 1, 2020 |
| CAH | CEO | Tax Withholding | 6,485 | $52.64 | $341,370 | Nov 8, 2020 |
| CAH | CEO | Tax Withholding | 26,775 | $53.68 | $1,437,282 | Aug 15, 2020 |
| CAH | CEO | Award / Grant | 2,717 | — | — | Aug 3, 2020 |
| CAH | CEO | Tax Withholding | 6,649 | $50.55 | $336,107 | Jun 28, 2020 |
| MSM | Option Exercise | 717 | — | — | Jan 29, 2020 | |
| MSM | Option Exercise | 581 | — | — | Jan 25, 2020 | |
| CAH | CEO | Tax Withholding | 2,487 | $55.03 | $136,860 | Dec 2, 2019 |
| CAH | CEO | Tax Withholding | 6,638 | $53.20 | $353,142 | Nov 8, 2019 |
| CAH | CEO and CFO | Award / Grant | 95,238 | — | — | Aug 15, 2019 |
| CAH | Chief Executive Officer | Award / Grant | 63,694 | — | — | Jun 28, 2019 |
| MSM | Option Exercise | 16 | — | — | Jan 25, 2019 | |
| CAH | Chief Executive Officer | Tax Withholding | 1,636 | $54.83 | $89,702 | Dec 3, 2018 |
| CAH | Chief Executive Officer | Tax Withholding | 7,354 | $53.65 | $394,542 | Nov 8, 2018 |
| CAH | Chief Executive Officer | Award / Grant | 71,642 | — | — | Aug 15, 2018 |
| MSM | Option Exercise | 555 | — | — | Jan 26, 2018 | |
| CAH | Chief Executive Officer | Sale | 18,586 | $73.90 | $1,373,505 | Jan 22, 2018 |
| MSM | Option Exercise | 982 | — | — | Jan 21, 2018 | |
| CAH | CFO | Tax Withholding | 551 | $59.19 | $32,614 | Dec 1, 2017 |
| CAH | CFO | Award / Grant | 49,188 | — | — | Nov 8, 2017 |
| CAH | CFO | Tax Withholding | 6,331 | $67.46 | $427,089 | Sep 15, 2017 |
| CAH | CFO | Award / Grant | 14,301 | — | — | Aug 15, 2017 |
| MSM | Option Exercise | 16 | — | — | Jan 21, 2017 | |
| CAH | CFO | Award / Grant | 13,034 | — | — | Nov 30, 2016 |
| CAH | CFO | Tax Withholding | 6,330 | $75.26 | $476,396 | Sep 15, 2016 |
| CAH | CFO | Tax Withholding | 14,780 | $83.60 | $1,235,608 | Aug 15, 2016 |
| CAH | CFO | Gift | 95 | — | — | Nov 25, 2015 |
| MSM | Award / Grant | 571 | — | — | Sep 24, 2015 | |
| CAH | CFO | Tax Withholding | 6,330 | $84.31 | $533,682 | Sep 15, 2015 |
| CAH | CFO | Tax Withholding | 8,770 | $82.27 | $721,508 | Sep 1, 2015 |
| CAH | CFO | Tax Withholding | 16,576 | $84.27 | $1,396,860 | Aug 15, 2015 |
| CAH | CFO | Gift | 140 | — | — | Aug 4, 2015 |
| CAH | CEO, Pharmaceutical Segment | Award / Grant | 40,021 | — | — | Sep 15, 2014 |
| CAH | CEO, Pharmaceutical Segment | Sale | 50,216 | $74.95 | $3,763,689 | Sep 4, 2014 |